Is Samrat Pharmachem Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Samrat Pharmachem Ltd (530125.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Samrat Pharmachem Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Samrat Pharmachem Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Samrat Pharmachem Ltd?

Muslim investors may consider investing in Samrat Pharmachem Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Samrat Pharmachem Ltd classified as HALAL?

Musaffa determines the Shariah status of Samrat Pharmachem Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Samrat Pharmachem Ltd updated?

The Shariah compliance status of Samrat Pharmachem Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Samrat Pharmachem Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Samrat Pharmachem Ltd?

You can check the latest Shariah compliance status of Samrat Pharmachem Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Samrat Pharmachem Ltd 530125.BO

₹213.95 ₹3.95 (1.88%) 1D

Last Updated: May 15, 12:00 AM·BSE

530125.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 23, 2026

Report Source: 2026 2nd Quarter Report

Samrat Pharmachem Ltd. Stock Analysis 530125.BO

India Materials Nano Cap Report: Q2, 2026

Samrat Pharmachem Ltd. engages in the manufacturing manufacturing and selling chemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 32 full-time employees. The firm is engaged in the business of pharmaceutical chemicals. Its products include 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, Calcium Iodate, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodine, Iodine Monochloride, Iodine Monochloride, Iodoquinol, Methyl Iodide, N-Iodo Succinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate. These products are offered for the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, painting and textile industries. The firm exports its products to geographics such as the United States, Europe, Africa, Asia, the Middle East and others.

Key Statistics of Samrat Pharmachem Ltd (530125.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹207.00₹217.80

Today's Open

₹210.00

Volume

2082.00

P/E Ratio (TTM)

9.14

52 Week Range

₹190.00₹420.00

Market Cap

654.94M

Avg. Volume

1802.77

Dividend Yield

0.48%

Financial Metrics & Statements of Samrat Pharmachem Ltd (530125.BO)

FAQ's for Samrat Pharmachem Ltd (530125.BO)

According to Musaffa’s Shariah screening methodology, Samrat Pharmachem Ltd (530125.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.